Johnson David Michael 4
4 · Aura Biosciences, Inc. · Filed Nov 9, 2023
Insider Transaction Report
Form 4
Johnson David Michael
Director
Transactions
- Purchase
Common Stock
2023-11-07$7.17/sh+47,000$336,990→ 65,000 total(indirect: By Trust) - Purchase
Common Stock
2023-11-08$7.30/sh+9,601$70,087→ 135,667 total - Purchase
Common Stock
2023-11-07$7.17/sh+76,000$544,920→ 126,066 total - Purchase
Common Stock
2023-11-08$7.30/sh+10,000$73,000→ 75,000 total(indirect: By Trust) - Purchase
Common Stock
2023-11-07$7.17/sh+47,000$336,990→ 65,000 total(indirect: By Trust) - Purchase
Common Stock
2023-11-08$7.30/sh+10,000$73,000→ 75,000 total(indirect: By Trust)
Holdings
- 139,672(indirect: By Velocity Capital Management)
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $6.50 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
- [F2]The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
- [F3]The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $7.22 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
- [F5]Velosity Capital Management LLC is an entity that the reporting person is the sole member of.